161 related articles for article (PubMed ID: 35664767)
1. LncRNA-AL035458.2/hsa-miR-181a-5p Axis-Mediated High Expression of NCAPG2 Correlates With Tumor Immune Infiltration and Non-Small Cell Lung Cancer Progression.
Chen X; Guo J; Ren W; Zhou F; Niu X; Jiang X
Front Oncol; 2022; 12():910437. PubMed ID: 35664767
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma.
Chen X; Guo J; Zhou F; Ren W; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():905871. PubMed ID: 35651789
[TBL] [Abstract][Full Text] [Related]
3. LncRNA-AC009948.5 promotes invasion and metastasis of lung adenocarcinoma by binding to miR-186-5p.
Bai J; Li H; Chen X; Chen L; Hu Y; Liu L; Zhao Y; Zuo W; Zhang B; Yin C
Front Oncol; 2022; 12():949951. PubMed ID: 36059662
[TBL] [Abstract][Full Text] [Related]
4. Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma.
Chen X; Guo J; Zhou F; Ren W; Pu J; Mutti L; Niu X; Jiang X
Front Oncol; 2022; 12():895708. PubMed ID: 35646670
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of lncRNA-AC087588.2 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator.
Jiang X; Chen X; Guo J; Zhou F; Pu J; Mutti L; Niu X
Front Mol Biosci; 2022; 9():923584. PubMed ID: 35769906
[TBL] [Abstract][Full Text] [Related]
6. LINC00467 Is Upregulated by DNA Copy Number Amplification and Hypomethylation and Shows ceRNA Potential in Lung Adenocarcinoma.
Wang W; Bo H; Liang Y; Li G
Front Endocrinol (Lausanne); 2021; 12():802463. PubMed ID: 35095769
[TBL] [Abstract][Full Text] [Related]
7. NcRNA-Mediated High Expression of
Jiang X; Tang L; Yuan Y; Wang J; Zhang D; Qian K; Cho WC; Duan L
Front Oncol; 2022; 12():846536. PubMed ID: 35311097
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation Prognostic Impact of MiRNA-30a-5p in Lung Adenocarcinoma.
Jiang X; Yuan Y; Tang L; Wang J; Zhang D; Cho WC; Duan L
Front Oncol; 2022; 12():831997. PubMed ID: 35127546
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-AC02278.4 Is a Novel Prognostic Biomarker That Promotes Tumor Growth and Metastasis in Lung Adenocarcinoma.
Chen X; Zhou F; Ren W; Guo J; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():860961. PubMed ID: 35463380
[TBL] [Abstract][Full Text] [Related]
10. Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1.
Duan L; Wang J; Zhang D; Yuan Y; Tang L; Zhou Y; Jiang X
Front Oncol; 2022; 12():862564. PubMed ID: 35600383
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
Liu T; Yang C; Wang W; Liu C
Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-125b-5p Correlates With Prognosis and Lung Adenocarcinoma Progression.
Tang L; Yuan Y; Zhai H; Wang J; Zhang D; Liang H; Shi Y; Duan L; Jiang X
Front Mol Biosci; 2021; 8():788690. PubMed ID: 35187068
[TBL] [Abstract][Full Text] [Related]
13. Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and
Li X; Chen X; Yuan Y; Zhai R; Cho WC; Jiang X
Front Oncol; 2022; 12():916947. PubMed ID: 35707363
[TBL] [Abstract][Full Text] [Related]
14. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma.
Zhan P; Xi GM; Zhang B; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu Q; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Lv TF; Song Y
J Cell Mol Med; 2017 Apr; 21(4):665-676. PubMed ID: 27862966
[TBL] [Abstract][Full Text] [Related]
15. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the Role of Shugoshin-Like Protein 1 in Lung Adenocarcinoma: A Comprehensive Analysis and
Yuan Y; Wang J; Zhang D; Tang L; Duan L; Jiang X
Front Oncol; 2022; 12():898920. PubMed ID: 35592680
[TBL] [Abstract][Full Text] [Related]
17. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
Tan J; Wang W; Song B; Song Y; Meng Z
Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator.
Li X; Yuan Y; Pal M; Jiang X
Front Oncol; 2022; 12():929655. PubMed ID: 35719962
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of lncRNA DRAIC and miR-3940-3p in Lung Adenocarcinoma and Their Effect on Lung Adenocarcinoma Cell Progression.
Liu Z; Yang S; Zhou S; Dong S; Du J
Cancer Manag Res; 2021; 13():8367-8376. PubMed ID: 34764698
[TBL] [Abstract][Full Text] [Related]
20. microRNA-375 inhibits the malignant behaviors of hepatic carcinoma cells by targeting NCAPG2.
Dai HT; Wang ST; Chen B; Tang KY; Li N; Wen CY; Wan Y; Zhang GY; Huang YH; Geng ZJ
Neoplasma; 2022 Jan; 69(1):16-27. PubMed ID: 34818025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
